Dongwha Pharm (000020)

Currency in KRW
6,100
-60(-0.97%)
Closed·
000020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
6,0006,160
52 wk Range
5,5607,140
Key Statistics
Bid/Ask
6,080.00 / 6,100.00
Prev. Close
6,160
Open
6,160
Day's Range
6,000-6,160
52 wk Range
5,560-7,140
Volume
81.5K
Average Volume (3m)
67.57K
1-Year Change
-1.454%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000020 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Dongwha Pharm Company Profile

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.

Employees
826

Compare 000020 to Peers and Sector

Metrics to compare
000020
Peers
Sector
Relationship
P/E Ratio
22.2x8.8x−0.5x
PEG Ratio
−18.58−0.140.00
Price/Book
0.4x0.8x2.6x
Price / LTM Sales
0.3x0.6x3.3x
Upside (Analyst Target)
-29.6%48.1%
Fair Value Upside
Unlock11.9%7.7%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 273.72%
Dividend Yield
2.95%
Industry Median 0.81%
Annualized payout
180.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
35.00 / --
Revenue / Forecast
122.00B / --
EPS Revisions
Last 90 days

000020 Income Statement

People Also Watch

391,500
307950
-5.89%
100,000.00
457190
-5.30%
2,211,000
298040
-5.27%
58,900
353200
+0.51%
83,800
001430
+4.36%

FAQ

What Is the Dongwha Pharm (000020) Stock Price Today?

The Dongwha Pharm stock price today is 6,100

What Stock Exchange Does Dongwha Pharm Trade On?

Dongwha Pharm is listed and trades on the Seoul Stock Exchange.

What Is the Stock Symbol for Dongwha Pharm?

The stock symbol for Dongwha Pharm is "000020."

Does Dongwha Pharm Pay Dividends? What’s The Current Dividend Yield?

The Dongwha Pharm dividend yield is 2.95%.

What Is the Dongwha Pharm Market Cap?

As of today, Dongwha Pharm market cap is 170.74B.

What Is Dongwha Pharm's Earnings Per Share (TTM)?

The Dongwha Pharm EPS (TTM) is 273.72.

When Is the Next Dongwha Pharm Earnings Date?

Dongwha Pharm will release its next earnings report on Mar 18, 2026.

From a Technical Analysis Perspective, Is 000020 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Dongwha Pharm Stock Split?

Dongwha Pharm has split 3 times.

How Many Employees Does Dongwha Pharm Have?

Dongwha Pharm has 826 employees.

What is the current trading status of Dongwha Pharm (000020)?

As of Feb 06, 2026, Dongwha Pharm (000020) is trading at a price of 6,100, with a previous close of 6,160. The stock has fluctuated within a day range of 6,000 to 6,160, while its 52-week range spans from 5,560 to 7,140.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.